Morepen Laboratories Ltd Quarterly Results

Gross Sales

465.85

452.78

437.73

455.22

423.07

Excise Duty

0

0

0

0

0

Net Sales

465.85

452.78

437.73

455.22

423.07

Other Operating Income

0

0

0

0

0

Other Income

4.61

5.34

4.99

3.43

4.24

Total Income

470.46

458.12

442.71

458.64

427.32

Total Expenditure

423.61

416.64

393.66

403.6

374.69

PBIDT

46.85

41.48

49.06

55.05

52.62

Interest

4.67

1.34

1.18

1.15

0.8

PBDT

42.18

40.14

47.88

53.89

51.83

Depreciation

16.47

4.93

1.86

5.73

9.62

Minority Interest Before NP

0

0

0

0

0

Tax

0.68

8.52

11.17

12

13.9

Deferred Tax

4.73

0

0

0

-0.44

Reported Profit After Tax

20.31

26.69

34.85

36.17

28.74

Minority Interest After NP

-0.01

0

0

0

0.46

Net Profit after Minority Interest

20.32

26.69

34.85

36.17

28.28

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

20.32

26.69

34.85

36.17

28.28

EPS (Unit Curr.)

0.35

0.49

0.65

0.71

0.54

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

109.58

109.58

109.58

102.23

102.23

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

10.05

9.16

11.2

12.09

12.43

PBDTM(%)

9.05

8.86

10.93

11.83

12.25

PATM(%)

4.35

5.89

7.96

7.94

6.79